MARKET

EVH

EVH

Evolent Health Inc
NYSE

Real-time Quotes | Nasdaq Last Sale

29.43
+0.47
+1.62%
After Hours: 29.43 0 0.00% 16:01 05/20 EDT
OPEN
29.31
PREV CLOSE
28.96
HIGH
29.85
LOW
28.43
VOLUME
719.08K
TURNOVER
0
52 WEEK HIGH
34.60
52 WEEK LOW
18.33
MARKET CAP
2.70B
P/E (TTM)
-103.6998
1D
5D
1M
3M
1Y
5Y
--Piper Sandler Adjusts Evolent Health Price Target to $35 From $37, Maintains Overweight Rating
MT Newswires · 3d ago
Evolent Health to Participate in Upcoming Investor Conferences
Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that Chief Executive Officer Seth Blackley, Chief Financial Officer John Johnson and Vic...
PR Newswire · 05/09 20:15
The 3.7% return this week takes Evolent Health's (NYSE:EVH) shareholders three-year gains to 96%
By buying an index fund, investors can approximate the average market return. But if you pick the right individual...
Simply Wall St. · 05/09 19:40
Canaccord Genuity Maintains Buy Rating for Evolent Health: Here's What You Need To Know
Canaccord Genuity has decided to maintain its Buy rating of Evolent Health (NYSE:EVH) and raise its price target from $40.00 to $45.00. Shares of Evolent Health are trading down 2.43% over the last 24 hours, at $27.84 per share.
Benzinga · 05/09 16:00
--Canaccord Genuity Adjusts Evolent Health's Price Target to $45 from $40, Keeps Buy Rating
MT Newswires · 05/09 13:16
BRIEF-Evolent Health Announces First Quarter 2022 Results
reuters.com · 05/04 22:24
Evolent Health Q1 EPS $0.12 Up From $(0.01) YoY, Sales $297.10M Beat $286.77M Estimate
Evolent Health (NYSE:EVH) reported quarterly earnings of $0.12 per share. This is a 1300 percent increase over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $297.10
Benzinga · 05/04 21:14
Evolent Health Non-GAAP EPS of $0.12 beats by $0.13, revenue of $297.06M beats by $10.25M
Evolent Health press release (NYSE:EVH): Q1 Non-GAAP EPS of $0.12 beats by $0.13. Revenue of $297.06M (+38.1% Y/Y) beats by $10.25M. Full Year 2022 Guidance Revenue for the year ending
Seekingalpha · 05/04 21:03
More
No Data
Learn about the latest financial forecast of EVH. Analyze the recent business situations of Evolent Health Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 7 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

57.14%Strong Buy
42.86%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average EVH stock price target is 41.33 with a high estimate of 45.00 and a low estimate of 35.00.
High45.00
Average41.33
Low35.00
Current 29.43
EPS
Actual
Estimate
-0.000.040.070.11
Q2 2021
Q3 2021
Q4 2021
  • 0
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 308
Institutional Holdings: 105.74M
% Owned: 115.45%
Shares Outstanding: 91.59M
TypeInstitutionsShares
Increased
71
6.81M
New
39
1.65M
Decreased
63
5.65M
Sold Out
38
2.94M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.36%
Healthcare Equipment & Supplies
+0.36%
Key Executives
Non-Executive Chairman/Co-Founder
Frank Williams
Chief Executive Officer/Co-Founder/Director
Seth Blackley
Chief Financial Officer
John Johnson
Chief Operating Officer
Steve Tutewohl
Chief Accounting Officer/Controller
Aammaad Shams
General Counsel
Jonathan Weinberg
Lead Director/Independent Director
Cheryl Scott
Director
David Farner
Director
Diane Holder
Independent Director
Craig Barbarosh
Independent Director
M. Bridget Duffy
Independent Director
Peter Grua
Independent Director
Kim Keck
Independent Director
Tunde Sotunde
No Data
No Data
About EVH
Evolent Health, Inc. is a health care company that delivers clinical and administrative solutions to payers and providers. The Company supports health systems and physician organizations as well as health plans to move their business models from traditional fee for service reimbursement to value-based care. The Company operates through two segments: Evolent Health Services and Clinical Solutions. Its Evolent Health Services segment houses its administrative simplification solution and certain supporting population health infrastructure. Its Clinical Solutions segment includes its specialty management and physician-oriented total cost of care solutions, along with the New Century Health and Evolent Care Partners brands. Its New Century Health is a national population health provider in managing specialty care for medicare, commercial and medicaid members under performance-based arrangements, focused primarily on oncology and cardiovascular care.

Webull offers kinds of Evolent Health Inc stock information, including NYSE:EVH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EVH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading EVH stock methods without spending real money on the virtual paper trading platform.